Advertisement
Research Topics
Subscribe to Research Topics
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

New Trial Will Explore Heart Disease Prevention in People with HIV

October 28, 2014 9:44 am | News | Comments

The National Institutes of Health and The National Heart, Lung and Blood Institute are initiating a landmark multimillion dollar outcomes trial utilizing pitavastatin for the primary prevention of cardiovascular disease in persons infected with HIV. Read more... 

Drug Combination Shows Promise As Powerful Breast Cancer Treatment

October 28, 2014 9:23 am | News | Comments

Doctors discovered a potent drug combination that shows promise as a powerful treatment for breast cancer. Read more...                        

5,000 Ebola Healthcare Workers Needed in West Africa

October 28, 2014 9:07 am | by Elias Meseret - Associated Press | News | Comments

More than 5,000 additional health care workers are needed to fight Ebola in the three most affected countries in West Africa. Read more...                    

Advertisement

BMS Acquires Worldwide Rights For New Breast Cancer Therapy

October 28, 2014 8:57 am | News | Comments

Bristol-Myers Squibb Company entered into an agreement F-star Alpha to acquire the company and gain worldwide rights to a targeted therapy that can treat breast and gastric cancer. Read more...           

Monitoring Lipid, Detergent Content in Biological Samples Using IR-Based Spectrometry

October 27, 2014 4:01 pm | by Chandreyee Das, Ph.D., Senior Technical Writer, Protein Detection, EMD Millipore | Articles | Comments

Many biological samples in the course of drug development research are rich in lipid content, such as adipose tissue homogenates, brain and liver tissue extracts, lipemic samples and breast milk. Read more...

Merck Announces New Breakthrough Therapy Designation for Lung Cancer

October 27, 2014 1:37 pm | News | Comments

Merck announced that the FDA granted Breakthrough Therapy Designation for the treatment of lung cancer. Read more...                        

Actinium Announces Collaboration Plan on New Program

October 27, 2014 1:23 pm | News | Comments

Actinium Pharmaceuticals and Albert Einstein College of Medicine of Yeshiva University started development of an antibody construct. Read more...                   

Researcher Adapting New Technologies for Fighting Worm Infections

October 27, 2014 1:08 pm | News | Comments

Recent breakthroughs may pave the way for vaccines and new drugs for those infected by parasitic helminths. Read more...                       

Advertisement

Heart Drug May Help Treat ALS, Mouse Study Shows

October 27, 2014 11:46 am | by Michael C. Purdy | News | Comments

Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of ALS, suggests new research at Washington University School of Medicine in St. Louis. Read more...          

Gene Link to Seizures in Children After MMR Vaccine

October 27, 2014 11:08 am | News | Comments

Scientists in Denmark said they had found genetic clues to explain why a small number of children have febrile seizures—brief convulsions—after receiving the measles, mumps and rubella (MMR) vaccine. Read more...

Valeant: We'll Bump Allergan Offer to $200 a Share

October 27, 2014 11:03 am | News | Comments

The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12%, which would mean $200 or more per share for the maker of Botox. Read more...

CSL to Acquire Novartis Influenza Vaccine Business

October 27, 2014 10:51 am | News | Comments

CSL Limited announced that it has agreed to acquire Novartis’ global influenza vaccine business for $275 million. The business will be combined with CSL’s subsidiary, bioCSL. Read more...

Drugmakers Bet on Ebola Vaccines, Treatments

October 27, 2014 10:46 am | by Matthew Perrone and Danica Kirka - Associated Press | News | Comments

Drugmakers are racing to develop vaccines and drugs to address the worst outbreak of Ebola in history. Read more...                        

Advertisement

New Research Offers Hope in Treating Sleeping Sickness

October 27, 2014 9:21 am | by Joe O'Connell | News | Comments

A new research paper presents hundreds of starting points for treating sleep sickness, a deadly disease that affects thousands of people annually. Read more...                 

Mali Rushes to Track Ebola After Toddler Dies

October 27, 2014 8:58 am | by Baba Ahmed - Associated Press | News | Comments

Mali - which shares a porous land border with Guinea - has long been seen as vulnerable to Ebola because of the large number of people moving back and forth between the two countries. Read more...           

Protein Discovery May Unlock New HIV Treatment

October 24, 2014 1:48 pm | News | Comments

Scientists at the Salk Institute have uncovered a new protein that participates in active HIV replication. Read more...                                                  

Cancer Innovation Forum Calls for Improving Research Progress

October 24, 2014 1:37 pm | News | Comments

At a time when cancer drug development is at a critical juncture, accelerating the delivery of promising new treatments will depend on one critical requirement: ensuring that patients, individually and collectively, are actively involved in the cancer research and drug development process from beginning to end.  Read more...

Newly Released Dallas Nurse to Meet With Obama

October 24, 2014 1:23 pm | by Jessica Gresko - Associated Press | News | Comments

 A nurse who caught Ebola while caring for the patient diagnosed in Dallas was released from a hospital Friday. Read more...                      

AstraZeneca's Cancer Drug Gets Positive CHMP Review

October 24, 2014 1:16 pm | News | Comments

AstraZeneca announced that the CHMP of the EMA has adopted a positive opinion recommending the marketing authorisation of Lynparza (olaparib) as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer. Read more...

Baxter Announces FDA Approval For New Hemophilia Drug

October 24, 2014 12:27 pm | News | Comments

Baxter International Inc. announced that the FDA has approved Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. Read more...                           

Researchers Find New Target for Treating Childhood Cancers

October 24, 2014 10:31 am | News | Comments

Scientists at the University of Liverpool have uncovered a new target for drugs that could battle a lethal childhood cancer known as neuroblastoma. Read more...                 

Myriad Establishes New Tumor Research Lab in Europe

October 24, 2014 10:18 am | News | Comments

Myriad Genetics Inc. announced it has established a Tumor BRACAnalysis CDx laboratory in Europe. Read more...                                                        

Study Finds Best Way to Treat Neck Pain

October 24, 2014 10:03 am | News | Comments

A multicenter study of 169 men and women with a common form of neck pain suggests that both spinal steroid injections and conservative treatment with physical therapy and painkillers work equally well to relieve pain in the short term. Read more...  

New Technique Achieved With Profound Implications for Drug Development

October 24, 2014 9:29 am | News | Comments

A team from The Scripps Research Institute has established a new C-H activation technique that opens the door to creating a broader range of pure molecules of one-handedness or “chirality” by eliminating previous starting-material limitations. Read more...

After 1st Ebola Case in NYC, 3 Others Quarantined

October 24, 2014 9:06 am | by Jonathan Lemire and Colleen Long - Associated Press | News | Comments

A doctor who became New York City's first Ebola patient was praised for getting treatment immediately upon showing symptoms. Read more...                     

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading